AlphaYou
Overview
Smart money at a glance
Filings to Oct 5, 2026Net selling: insiders sold $29.1M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$29.1M netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 1 added, 1 cutEven
Market overview
Fundamentals Oct 5- Open
- $52.36
- 52-wk high
- $57.73
- High
- $53.47
- 52-wk low
- $30.74
- Low
- $52.07
- Prev close
- $52.52
- Mkt cap
- $2.89B
- P/E
- 72.2x
- Volume
- 746.9K
- Fwd P/E
- 29.0x
- Beta
- 0.40
- P/S
- 7.0x
- P/B
- 8.3x
- Profit margin
- +9.8%
- Op margin
- +22.5%
- ROE
- +11.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about IMAX filings
Are insiders buying or selling Imax Corp (IMAX) stock?
Net selling: insiders sold $29.1M and bought $0 of IMAX stock on the open market in the 90 days to Oct 5, 2026, according to SEC Form 4 filings. $24M of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Gelfond, Richard L (Chief Executive Officer), who sold $24M. The latest filing was on Sep 11, 2026.
Which members of Congress have traded IMAX recently?
None. No member of Congress disclosed a IMAX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this IMAX smart-money data?
This summary uses filings available on Oct 5, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (2)
- MW
Marshall Wace
$13.4M
added
- JC
JPMorgan Chase
$28.5M
added
Sells/Trims (1)
- TS
Two Sigma
$15.1M
trimmed
What insiders are doing
How top traders are positioned
No tracked top-trader positions in IMAX right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 63.2% above what analysts expected.
Last report
Jul 23, 2026
Period ending
Jun 30, 2026
Earnings per share
$0.19 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 23, 2026 | $0.31 / $0.19Alpha Vantage | +63.16% beat | Unavailable | Unavailable |
| Mar 31, 2026 | Apr 30, 2026 | $0.17 / $0.15Alpha Vantage | +13.33% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 25, 2026 | $0.58 / $0.46Alpha Vantage | +26.20% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Oct 23, 2025 | $0.47 / $0.39Alpha Vantage | +20.51% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Jul 24, 2025 | $0.26 / $0.23Alpha Vantage | +13.04% beat | Unavailable | Unavailable |
| Mar 31, 2025 | Apr 23, 2025 | $0.13 / $0.11Alpha Vantage | +18.18% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 19, 2025 | $0.27 / $0.28Alpha Vantage | -4.26% miss | Unavailable | Unavailable |
| Sep 30, 2024 | Oct 30, 2024 | $0.35 / $0.24Alpha Vantage | +45.83% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Oct 22, 2026, in 17 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $106.7M | $125.2M | $81.4M | $102.8M |
| Cost of what it sold | $39.4M | $55.1M | $35.6M | $39.9M |
| Gross profit | $67.3M | $70.1M | $45.8M | $62.9M |
| What it spent | ||||
| Research and development | $1.5M | $1.5M | $1.8M | $1.7M |
| Sales and admin | $34.2M | $33.5M | $32.5M | $34.5M |
| Other operating costs | $2.5M | $2.8M | $1.6M | $5.9M |
| Total operating expenses | $38.2M | $37.8M | $35.9M | $42.1M |
| What was left | ||||
| Operating profit | $29.0M | $32.3M | $10.0M | $20.8M |
| Interest on debt | $1.8M | $1.8M | $1.9M | $2.0M |
| Profit before tax | $27.8M | $6.6M | $8.5M | $19.4M |
| Tax | $5.2M | $4.1M | $2.4M | $3.5M |
| Net profit | $20.7M | $637.0K | $4.2M | $15.4M |
| EBITDA | $45.3M | $24.4M | $25.6M | $34.8M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bullish
Imax Corp (IMAX) Stock Down 4.2% but Still Overvalued -- GF Scor
BearishOct 2437,023 Shares of IMAX Corporation $IMAX Bought by Bank of America Corp DE
Leans bullishSep 25Morgan Stanley Says Imax Is Now Essential for Theaters, Initiates With $63 Target
BullishSep 24IMAX Stock’s Rally May Be Just The Start, Morgan Stanley Says — Why ‘The Odyssey’ Is Reshaping The Moviegoing Experience
NeutralSep 24